A newly-published study from SickKids Hospital finds one solution helps vulnerable patients avoid hospitals by killing superbugs and preventing bloodstream infections
Powerful KiteLock™ 4% venous catheter lock solution, available by Canadian company SterileCare, proven to significantly reduce preventable infections
TORONTO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Every single day, an estimated 34 Canadians1 die of preventable bloodstream infections acquired during hospitalization. A three-year study of pediatric patients with intestinal failure by the Hospital for Sick Children, University of Toronto and McMaster’s Children’s Hospital, McMaster University, found that use of KiteLockTM 4% solution is effective in significantly reducing catheter bloodstream infections and occlusions in pediatric patients who require prolonged use venous catheters. According to the National Institute of Health, 80% of these infections are caused by the formation of bacterial biofilm, many harbouring harmful bacteria such as superbugs in prolonged-use venous catheters, commonly used by vulnerable patients receiving chemotherapy, dialysis, nutrition or drug therapy.
Another recently-published three-year study of adult patients at high risk for central venous access device occlusion and catheter-related infection by Providence Health Care’s St. Paul’s Hospital, found that use of KiteLockTM 4% solution is effective in reducing venous catheter infections by 71% and eliminating occlusions. The study also shows that the use of KiteLock™ 4% helped significantly avoid or reduce hospital stays and represented a whopping 63% reduction in cost over 24 months.
Click here for the full story on the Financial Post.